SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stefano Omboni, Ettore Malacco, Jean-Michel Mallion, Paolo Fabrizzi, Massimo Volpe, Olmesartan vs. Ramipril in Elderly Hypertensive Patients: Review of Data from Two Published Randomized, Double-Blind Studies, High Blood Pressure & Cardiovascular Prevention, 2014, 21, 1, 1

    CrossRef

  2. You have free access to this content2
    Lewis Landsberg, Louis J. Aronne, Lawrence J. Beilin, Valerie Burke, Leon I. Igel, Donald Lloyd-Jones, James Sowers, Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment, The Journal of Clinical Hypertension, 2013, 15, 1
  3. 3
    Lewis Landsberg, Louis J. Aronne, Lawrence J. Beilin, Valerie Burke, Leon I. Igel, Donald Lloyd-Jones, James Sowers, Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment—A position paper of the The Obesity Society and the American Society of Hypertension, Obesity, 2013, 21, 1
  4. 4
    Rodrigo Neto-Ferreira, Vinícius Novaes Rocha, Vanessa Souza-Mello, Carlos Alberto Mandarim-de-Lacerda, Jorge José de Carvalho, Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 mice, Diabetology & Metabolic Syndrome, 2013, 5, 1, 32

    CrossRef

  5. 5
    Stefano Omboni, Ettore Malacco, Jean-Michel Mallion, Massimo Volpe, Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic Syndrome, Drugs & Aging, 2012, 29, 12, 981

    CrossRef

  6. 6
    Marina De Marco, Giovanni de Simone, Raffaele Izzo, Costantino Mancusi, Alfonso Sforza, Renata Giudice, Bruno Trimarco, Nicola De Luca, Classes of antihypertensive medications and blood pressure control in relation to metabolic risk factors, Journal of Hypertension, 2012, 30, 1, 188

    CrossRef

  7. 7
    Bernard M. Y. Cheung, Chao Li, Diabetes and Hypertension: Is There a Common Metabolic Pathway?, Current Atherosclerosis Reports, 2012, 14, 2, 160

    CrossRef

  8. 8
    B. Huisamen, S. J. C. Pêrel, S. O. Friedrich, R. Salie, H. Strijdom, A. Lochner, ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance, Molecular and Cellular Biochemistry, 2011, 349, 1-2, 21

    CrossRef

  9. You have free access to this content9
    Yehuda Handelsman, Diabetes and Hypertension: A Comprehensive Report on Management and the Prevention of Cardiovascular and Renal Complications, The Journal of Clinical Hypertension, 2011, 13, 4
  10. You have free access to this content10
    Prakash Deedwania, Hypertension, Dyslipidemia, and Insulin Resistance in Patients With Diabetes Mellitus or the Cardiometabolic Syndrome: Benefits of Vasodilating β-Blockers, The Journal of Clinical Hypertension, 2011, 13, 1
  11. You have free access to this content11
    Willa A. Hsueh, Kathleen Wyne, Renin-Angiotensin-Aldosterone System in Diabetes and Hypertension, The Journal of Clinical Hypertension, 2011, 13, 4
  12. 12
    Daiju Fukuda, Soichiro Enomoto, Yoichiro Hirata, Ryozo Nagai, Masataka Sata, The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice, Biomedicine & Pharmacotherapy, 2010, 64, 10, 712

    CrossRef

  13. 13
    J. Alberto Olivares-Reyes, Araceli Arellano-Plancarte, J. Ramon Castillo-Hernandez, Angiotensin II and the development of insulin resistance: Implications for diabetes, Molecular and Cellular Endocrinology, 2009, 302, 2, 128

    CrossRef

  14. 14
    Miki Nagase, Toshiro Fujita, Mineralocorticoid receptor activation in obesity hypertension, Hypertension Research, 2009, 32, 8, 649

    CrossRef

  15. 15
    Norihiro Kato, Yi-Qiang Liang, Yoshinori Ochiai, Naoko Birukawa, Masakuni Serizawa, Subrina Jesmin, Candesartan-Induced Gene Expression in Five Organs of Stroke-Prone Spontaneously Hypertensive Rats, Hypertension Research, 2008, 31, 10, 1963

    CrossRef

  16. 16
    Marlen Damjanovi, Matthias Barton, Fat intake and cardiovascular response, Current Hypertension Reports, 2008, 10, 1, 25

    CrossRef

  17. 17
    Adela Penesova, Zofia Radikova, Eva Cizmarova, Richard Kvetňanský, Pavel Blazicek, Miroslav Vlcek, Juraj Koska, Milan Vigas, The Role of Norepinephrine and Insulin Resistance in an Early Stage of Hypertension, Annals of the New York Academy of Sciences, 2008, 1148, 1
  18. 18
    Emilio A Francischetti, Bruno MJ Celoria, Aloisio Francischetti, Virginia A Genelhu, Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan, Expert Review of Cardiovascular Therapy, 2008, 6, 3, 289

    CrossRef

  19. 19
    José A. García-Donaire, Luis M. Ruilope, Hypertension and Cardiovascular Disease and Its Management,